![Jin Li](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 546 M $ al 30/09/2026
Jin Li is the founder of HitGen, Inc. established in 2012, where he holds the title of Chairman & General Manager.
He is currently the Director at HitGen UK Ltd. since 2020.
Dr. Li was previously the Director at Phynova Group Ltd. from 2008 to 2009.
He received his doctorate degree from the University of Aston in 1988.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
HITGEN INC. CLASS A 20,46 % | 22/09/2026 | 81.970.948 ( 20,46 % ) | 546 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| HITGEN INC. | Director Ejecutivo | 01/06/2012 |
HitGen UK Ltd.
 HitGen UK Ltd. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company | Director/Miembro de la Junta | 05/10/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
Phynova Group Ltd.
 Phynova Group Ltd. Pharmaceuticals: OtherHealth Technology Operates as a life science company that develops and commercializes natural health ingredients powered by plants | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Phynova Group Ltd.
Phynova Group Ltd. Pharmaceuticals: OtherHealth Technology Operates as a life science company that develops and commercializes natural health ingredients powered by plants | Health Technology |
University of Aston
 University of Aston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HitGen, Inc.
 HitGen, Inc. BiotechnologyHealth Technology Develops innovative drugs | Health Technology |
HitGen UK Ltd.
HitGen UK Ltd. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
